Clinical trial registry record

Evaluation of In-Vitro Cryo Therapeutic Protocols on Human Cell Samples (TWH-CRYO-001)

A registered EARLY_PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Enrolling By Invitation. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Enrolling By Invitation.
Evidence
Registered early phase 1 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated January 6, 2026.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT07321028
Last registry update
January 6, 2026
Status
Enrolling By Invitation
Phase
EARLY Phase 1
Sponsor
Truway Health, Inc.
Enrollment
50
Countries
United States
Match confidence
90%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered EARLY_PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Enrolling By Invitation. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
EARLY Phase 1
Study design
NON RANDOMIZED · PARALLEL · TREATMENT · NONE
Evidence population
Human clinical study registration
Participants
50
Population
ALL
Duration
2025-12-10 to 2066-12-10
Intervention
Standard Laboratory Cryopreservation Procedure; Enhanced Laboratory Cryopreservation Procedure; Normothermic Cell Culture Control
Comparator
Not reported
Outcomes measured
Post-Thaw Viability — Twenty-four (24) hours after thaw; Cell Proliferation and Long-Term Viability at 7 Days — Seven (7) days after thaw; Apoptosis and Necrosis Marker Expression at 24 and 72 Hours — Twenty-four (24) hours and seventy-two (72) hours after t…; Cellular Metabolic and Functional Integrity from 24 Hours to 7 Days — From twenty-four (24) hours through seven (7) day…; Morphological Integrity at 24 Hours — Twenty-four (24) hours after thaw
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · EARLY Phase 1A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 90% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Cryobiology · 90%Summary contains controlled topic terminology. Source terminology contains a controlled topic term.

Automated source check 100% · update recency 85%. These figures help sort records; they are not medical ratings.

cryobiology
Read the original source →Export JSON